The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Perspective: Hypothesis: Serum IgG Antibody Is Sufficient to Confer Protection against Infectious Diseases by Inactivating the Inoculum
Abstract
The theory proposed is that a critical level of specific serum IgG is sufficient to confer protection against infectious diseases by inactivating the inoculum of the pathogen. This theory relies heavily on evaluation of licensed vaccines and includes the following: Measurement of serum antibodies only reliably predicts the efficacy of vaccines, according to regulatory agencies. Serum IgG antibodies alone account for the protection conferred by passive immunization. "Herd" immunity conferred by vaccines on viral and bacterial diseases is best explained by serum antibodies that inactivate the inoculum on mucosal surfaces, thus reducing the pathogen's transmission. Once the disease is manifest, serum antibodies induced by active immunization will neither relieve symptoms nor eliminate the pathogen; specific IgG must be present when the host encounters the pathogen in order to confer protective immunity. Information about the initial pathogen-host contact is vital, whereas knowledge of the symptomatology of the disease may not be essential for vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Goldschneider, I., Gotschlich, E. C., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1307 · Cited by 1,294
Genotypic and Phenotypic Characterization of HIV-1 Patients with Primary Infection
Zhu, T., Mo, H., Wang, N., Nam, D. S., Cao, Y., Koup, R. A., & Ho, D. D. (1993) · Science · doi:10.1126/science.8356453 · Cited by 1,249
Serology, chemistry, and genetics of O and K antigens of Escherichia coli
Orskov, I., Orskov, F., Jann, B., & Jann, K. (1977) · Bacteriological Reviews · doi:10.1128/br.41.3.667-710.1977 · Cited by 933
Groothuis, J. R., Simoes, E., Levin, M. J., Hall, C. B., Long, C. E., Rodriguez, W. J., Arrobio, J., Meissner, H. C., Fulton, D. R., Welliver, R. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311183292102 · Cited by 744 · cited 1×
“Passive immunization has also been shown to prevent diseases caused by CMV and RSV [62, 63].”
BackgroundWaldmann, T. A., & Strober, W. (2015) · Chemical Immunology and Allergy · doi:10.1159/000385919 · Cited by 723
Farmer, J. J., Davis, B. R., Hickman-Brenner, F. W., McWhorter, A., Huntley-Carter, G. P., Asbury, M. A., Riddle, C., Wathen-Grady, H. G., Elias, C., & Fanning, G. R. (1985) · Journal of Clinical Microbiology · doi:10.1128/jcm.21.1.46-76.1985 · Cited by 707
Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era
Adams, W. G. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500020055031 · Cited by 696
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development
Levine, M. M., Kaper, J. B., Black, R. E., & Clements, M. L. (1983) · Microbiological Reviews · doi:10.1128/mmbr.47.4.510-550.1983 · Cited by 636
Schneerson, R., Barrera, O., Sutton, A., & Robbins, J. B. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.2.361 · Cited by 625
Self-citationInoculum Size in Shigellosis and Implications for Expected Mode of Transmission
DuPont, H. L., Levine, M. M., Hornick, R. B., & Formal, S. B. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.6.1126 · Cited by 620
Snydman, D. R., Werner, B. G., Heinze-Lacey, B., Berardi, V. P., Tilney, N. L., Kirkman, R. L., Milford, E. L., Cho, S. I., Bush, H. L., Levey, A. S., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710223171703 · Cited by 570
Krugman, S. (1967) · JAMA · doi:10.1001/jama.200.5.365 · Cited by 556
A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children
Werzberger, A., Mensch, B., Kuter, B., Brown, L., Lewis, J., Sitrin, R., Miller, W., Shouval, D., Wiens, B., Calandra, G., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208133270702 · Cited by 540
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
MacLeod, C. M., Hodges, R. G., Heidelberger, M., & Bernhard, W. G. (1945) · Journal of Experimental Medicine · doi:10.1084/jem.82.6.445 · Cited by 518
Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up
CLEMENS, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)90080-o · Cited by 505
Zhang, L. Q., MacKenzie, P., Cleland, A., Holmes, E. C., Brown, A. J., & Simmonds, P. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3345-3356.1993 · Cited by 468
A Review of Human Salmonellosis: I. Infective Dose
Blaser, M. J., & Newman, L. S. (1982) · Clinical Infectious Diseases · doi:10.1093/clinids/4.6.1096 · Cited by 460
The Gamma Globulins: The Antibody Deficiency Syndromes
Rosen, F. S., & Janeway, C. A. (1966) · New England Journal of Medicine · doi:10.1056/nejm196609292751307 · Cited by 407
Ogra, P. L., Karzon, D. T., Righthand, F., & MacGillivray, M. (1968) · New England Journal of Medicine · doi:10.1056/nejm196810242791701 · Cited by 397
Prevention of Typhoid Fever in Nepal with the VI Capsular Polysaccharide of Salmonella Typhi
Acharya, I. L., Lowe, C. U., Thapa, R., Gurubacharya, V. L., Shrestha, M. B., Cadoz, M., Schulz, D., Armand, J., Bryla, D. A., Trollfors, B., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710293171801 · Cited by 387
Self-citationTakala, A. K., Eskola, J., Leinonen, M., Kayhty, H., Nissinen, A., Pekkanen, E., & Makela, P. H. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/164.5.982 · Cited by 377
Large outbreak of clinical cholera due to Vibrio cholerae non-01 in Bangladesh
John Albert, M., Siddique, A. K., Islam, M. S., Faruque, A. S. G., Ansaruzzaman, M., Faruque, S. M., & Bradley Sack, R. (1993) · The Lancet · doi:10.1016/0140-6736(93)90481-u · Cited by 354
LARGE-SCALE FIELD TRIAL OF TY21A LIVE ORAL TYPHOID VACCINE IN ENTERIC-COATED CAPSULE FORMULATION
Levine, M., Black, R., Ferreccio, C., & Germanier, R. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90480-6 · Cited by 351
The Role of Viral Glycoproteins in Adsorption, Penetration, and Pathogenicity of Viruses
Choppin, P. W., & Scheid, A. (1980) · Clinical Infectious Diseases · doi:10.1093/clinids/2.1.40 · Cited by 345
Protection against Cholera in Breast-Fed Children by Antibodies in Breast Milk
Glass, R. I., Svennerholm, A.-M., Stoll, B. J., Khan, M. R., Hossain, K. M. B., Hug, M. I., & Holmgren, J. (1983) · New England Journal of Medicine · doi:10.1056/nejm198306093082304 · Cited by 341
Fothergill, L. D., & Wright, J. (1933) · The Journal of Immunology · Cited by 334
IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole.
High, N., Mounier, J., Prévost, M. C., & Sansonetti, P. J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05253.x · Cited by 317
PROTECTIVE ACTIVITY OF VI CAPSULAR POLYSACCHARIDE VACCINE AGAINST TYPHOID FEVER
Klugman, K., Koornhof, H., Schneerson, R., Cadoz, M., Gilbertson, I., Robbins, J., Schulz, D., & Armand, J. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91316-x · Cited by 307
Self-citationAustrian, R. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.supplement_1.s1 · Cited by 292
Robbins, J. B., Parke, J. C., Schneerson, R., & Whisnant, J. K. (1973) · Pediatric Research · doi:10.1203/00006450-197303000-00001 · Cited by 291
Self-citationBeasley, P. R., Hwang, L.-Y., Stevens, C. E., Lin, C.-C., Hsieh, F.-J., Wang, K.-Y., Sun, T.-S., & Szmuness, W. (1983) · Hepatology · doi:10.1002/hep.1840030201 · Cited by 290
Fulginiti, V. A. (1967) · JAMA · doi:10.1001/jama.1967.03130250057008 · Cited by 273
Reexamination of the Protective Role of the Capsular Polysaccharide (Vi antigen) of Salmonella typhi
Robbins, J. D., & Robbins, J. B. (1984) · Journal of Infectious Diseases · doi:10.1093/infdis/150.3.436 · Cited by 247
Self-citationPrince, G. A., Horswood, R. L., & Chanock, R. M. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.517-520.1985 · Cited by 245 · cited 1×
“It is not commonly appreciated that serum IgG antibodies, as well as locally synthesized immunoglobulins, are found on the mucosal surfaces of respiratory [80, 81] and intestinal tracts [82-86] and on the cervix [87, 88].”
BackgroundVialard, J., Lalumière, M., Vernet, T., Briedis, D., Alkhatib, G., Henning, D., Levin, D., & Richardson, C. (1990) · Journal of Virology · doi:10.1128/jvi.64.1.37-50.1990 · Cited by 242
Barenkamp, S. J., & Leininger, E. (1992) · Infection and Immunity · doi:10.1128/iai.60.4.1302-1313.1992 · Cited by 232
Clements, M. L., & Murphy, B. R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.23.1.66-72.1986 · Cited by 230
Ferreccio, C., Prado, V., Ojeda, A., Cayyazo, M., Abrego, P., Guers, L., & Levine, M. M. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116134 · Cited by 214
Conley, A. J., Gorny, M. K., Kessler, J. A., Boots, L. J., Ossorio-Castro, M., Koenig, S., Lineberger, D. W., Emini, E. A., Williams, C., & Zolla-Pazner, S. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.6994-7000.1994 · Cited by 211
HUMAN IMMUNITY TO THE MENINGOCOCCUS
Gotschlich, E. C., Goldschneider, I., & Artenstein, M. S. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.129.6.1385 · Cited by 199
Chu, C., Schneerson, R., Robbins, J. B., & Rastogi, S. C. (1983) · Infection and Immunity · doi:10.1128/iai.40.1.245-256.1983 · Cited by 195
Self-citationMurphy, T. V., Pastor, P., Medley, F., Osterholm, M. T., & Granoff, D. M. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83529-2 · Cited by 190
Robbins, J. B., Chu, C., & Schneerson, R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/15.2.346 · Cited by 179
Self-citationFaden, H., Modlin, J. F., Thoms, M. L., McBean, A. M., Ferdon, M. B., & Ogra, P. L. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/162.6.1291 · Cited by 178
Anderson, P. (1983) · Infection and Immunity · doi:10.1128/iai.39.1.233-238.1983 · Cited by 174
Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism
Moxon, E. R., & Murphy, P. A. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.3.1534 · Cited by 173
ORIGIN OF ANTI-HUMAN BLOOD GROUP B AGGLUTININS IN WHITE LEGHORN CHICKS
Springer, G. F., Horton, R. E., & Forbes, M. (1959) · The Journal of Experimental Medicine · doi:10.1084/jem.110.2.221 · Cited by 170
Norrby, E., Enders-Ruckle, G., & ter Meulen, V. (1975) · The Journal of Infectious Diseases · doi:10.1093/infdis/132.3.262 · Cited by 169
Johnson, J. A., Salles, C. A., Panigrahi, P., Albert, M. J., Wright, A. C., Johnson, R. J., & Morris, J. G. (1994) · Infection and Immunity · doi:10.1128/iai.62.5.2108-2110.1994 · Cited by 160
Santosham, M., Reid, R., Ambrosino, D. M., Wolff, M., Almeido-Hill, J., Priehs, C., Aspery, K. M., Garrett, S., Croll, L., Foster, S. L., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171503 · Cited by 133
EVALUATION OF RED CROSS GAMMA GLOBULIN AS A PROPHYLACTIC AGENT FOR POLIOMYELITIS
Hammon, W. M. (1952) · JAMA · doi:10.1001/jama.1952.03680080019003 · Cited by 105
Smith, C. B., Bellanti, J. A., & Chanock, R. M. (1967) · The Journal of Immunology · doi:10.4049/jimmunol.99.1.133 · Cited by 104
Specific immunoglobulin for treatment of whooping cough
Granström, M., Hanngren, K., Olinder-Nielsen, A. M., Holmblad, P., & Mark, A. (1991) · The Lancet · doi:10.1016/0140-6736(91)92101-7 · Cited by 102
van Wezel, A. L., van Steenis, G., Hannik, C. A., & Cohen, H. (1978) · PubMed · Cited by 100
Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children
Shurin, P. A., Rehmus, J. M., Johnson, C. E., Marchant, C. D., Carlin, S. A., Super, D. M., Hare, G. F. V., Jones, P. K., Ambrosino, D. M., & Siber, G. R. (1993) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80865-0 · Cited by 91
Weibel, R. E., Buynak, E. B., McLean, A. A., Roehm, R. R., & Hilleman, M. R. (1980) · Experimental Biology and Medicine · doi:10.3181/00379727-165-40967 · Cited by 77
Douglas, R. M., Hansman, D., Miles, H. B., & Paton, J. C. (1986) · American journal of diseases of children · doi:10.1001/archpedi.1986.02140250109044 · Cited by 76
Immune-Mediated Emigration of Neutrophils into the Lumen of the Small Intestine
Bellamy, J. E. C., & Nielsen, N. O. (1974) · Infection and Immunity · doi:10.1128/iai.9.4.615-619.1974 · Cited by 71
Use of Concentrated Human Serum gamma-Globulin in the Prevention and Attenuation of Measles.
(1945) · PubMed Central · Cited by 67
Cross-reactive antigens and immunity to diseases caused by encapsulated bacteria
Robbins, J. B., Schneerson, R., Glodé, M. P., Vann, W. F., Schiffer, M. S., Liu, T.-Y., Parke, J. C., & Huntley, C. C. (1975) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(75)90119-0 · Cited by 66
Self-citationThe Clinical Use of Gamma Globulin
Krugman, S. (1963) · New England Journal of Medicine · doi:10.1056/nejm196307252690406 · Cited by 63
Karaolis, D. K. R., Lan, R., & Reeves, P. R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.3.796-802.1994 · Cited by 53
Böttiger, M., & Herrström, E. (1992) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549209052605 · Cited by 50
Böttiger, M. (1984) · Clinical Infectious Diseases · doi:10.1093/clinids/6.supplement_2.s548 · Cited by 39
Rm, C., Crowe, J. E., Br, M., et al. (1993) · PubMed · Cited by 36
Sabin, A. B., Michaels, R. H., D, S. K. M., Eiger, M. E., Berman, P. H., & Warren, J. D. (1963) · PEDIATRICS · Cited by 34
GLEZEN, W. P., Lamb, G. A., Belden, E., & CHIN, T. D. Y. (1966) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120578 · Cited by 28
Floyd, T. M., Higgins, A., & Kader, M. A. (1956) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1956.5.119 · Cited by 26
Studies on Diarrheal Diseases in Central America
Beck, M. D., Muñoz, J. A., & Scrimshaw, N. S. (1957) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1957.6.62 · Cited by 25
Inactivated and live, attenuated poliovirus vaccines: mucosal immunity.
Sutter, R. W., & Patriarca, P. A. (1993) · Measles and Poliomyelitis · doi:10.1007/978-3-7091-9278-8_23 · Cited by 23 · cited 1×
“nized with an improved formalin-inactivated poliovirus vaccine (EIPV or Salk-type) [135, 136] for -30 years; compliance is almost 100(^.”
MethodPierce, N. F., & Reynolds, H. Y. (1975) · The Journal of Infectious Diseases · doi:10.1093/infdis/131.4.383 · Cited by 23
Effect of a Vi-degrading Enzyme on Potency of Typhoid Vaccines in Mice
Wong, K. H., Feeley, J. C., & Pittman, M. (1972) · The Journal of Infectious Diseases · doi:10.1093/infdis/125.4.360 · Cited by 23
Herd effect and virus eradication with use of killed poliovirus vaccine.
Salk, D. (1981) · PubMed · Cited by 15
Cited by
The convalescent sera option for containing COVID-19
Casadevall, A., & Pirofski, L.-A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138003 · Cited by 903
Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4009-4018.1999 · Cited by 783
Simek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00110-09 · Cited by 594
Kotloff, K. L., Riddle, M. S., Platts-Mills, J. A., Pavlinac, P., & Zaidi, A. K. M. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33296-8 · Cited by 577
Passive antibody therapy for infectious diseases
Casadevall, A., Dadachova, E., & Pirofski, L.-A. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro974 · Cited by 531
Metadata
- Authors
- Robbins, J. B., Schneerson, R., & Szu, S. C.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-06-01
- Volume
- 171
- Issue
- 6
- Pages
- 1387-1398
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2116058470
- Cited by
- 385
- References
- 73
- FWCI
- 7.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.